肝移植术后戊型肝炎病毒感染1例报告

邱爽; 陈虹; 范铁燕; 张庆; 李俊

doi:10.3969/j.issn.1001-5256.2021.10.029

肝移植术后戊型肝炎病毒感染1例报告

DOI: 10.3969/j.issn.1001-5256.2021.10.029

邱爽¹,
陈虹^2, ,,
范铁燕²,
张庆¹,
李俊³

1.
解放军总医院第三医学中心器官移植科, 北京 100089
2.
北京清华长庚医院肝移植科, 北京 100089
3.
天津市人民医院消化内科, 天津 300000

详细信息

通信作者:
陈虹，ch61520@163.com

中图分类号: R512.6; R617
计量
- 文章访问数: 372
- HTML全文浏览量: 98
- PDF下载量: 39
- 被引次数: 0
出版历程
- 收稿日期: 2021-03-03
- 录用日期: 2021-06-17
- 出版日期: 2021-10-20

Hepatitis E virus infection after liver transplantation: A case report

1.
Department of Organ Transplantation, The Third Medical Center of Chinese PLA General Hospital, Beijing 100089, China
2.
Department of Liver Transplantation, Beijing Tsinghua Changgung Hospital, Beijing 100089, China
3.
Department of Gastroenterology, Tianjin People's Hospital, Tianjin 300000, China

摘要

- 肝移植 /
- 戊型肝炎病毒 /
- 肝功能衰竭
- Liver Transplantation /
- Hepatitis E Virus /
- Liver Failure

HTML全文

参考文献(19)

[1]	KAMAR N, BENDALL R, LEGRAND-ABRAVANEL F, et al. Hepatitis E[J]. Lancet, 2012, 379(9835): 2477-2488. DOI: 10.1016/S0140-6736(11)61849-7.
[2]	ANKCORN MJ, TEDDER RS. Hepatitis E: The current state of play[J]. Transfus Med, 2017, 27(2): 84-95. DOI: 10.1111/tme.12405.
[3]	HAAGSMA EB, van den BERG AP, PORTE RJ, et al. Chronic hepatitis E virus infection in liver transplant recipients[J]. Liver Transpl, 2008, 14(4): 547-553. DOI: 10.1002/lt.21480.
[4]	COLSON P, KABA M, MOREAU J, et al. Hepatitis E in an HIV-infected patient[J]. J Clin Virol, 2009, 45(4): 269-271. DOI: 10.1016/j.jcv.2009.06.002.
[5]	DALTON HR, BENDALL RP, KEANE FE, et al. Persistent carriage of hepatitis E virus in patients with HIV infection[J]. N Engl J Med, 2009, 361(10): 1025-1027. DOI: 10.1056/NEJMc0903778.
[6]	PISCHKE S, SUNEETHA PV, BAECHLEIN C, et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients[J]. Liver Transpl, 2010, 16(1): 74-82. DOI: 10.1002/lt.21958.
[7]	HAAGSMA EB, NIESTERS HG, van den BERG AP, et al. Prevalence of hepatitis E virus infection in liver transplant recipients[J]. Liver Transpl, 2009, 15(10): 1225-1228. DOI: 10.1002/lt.21819.
[8]	HOERNING A, HEGEN B, WINGEN AM, et al. Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients-a single-center experience[J]. Pediatr Transplant, 2012, 16(7): 742-747. DOI: 10.1111/j.1399-3046.2012.01740.x.
[9]	LEGRAND-ABRAVANEL F, KAMAR N, SANDRES-SAUNE K, et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France[J]. Emerg Infect Dis, 2011, 17(1): 30-37. DOI: 10.3201/eid1701.100527.
[10]	PAS SD, de MAN RA, MULDERS C, et al. Hepatitis E virus infection among solid organ transplant recipients, the Netherlands[J]. Emerg Infect Dis, 2012, 18(5): 869-872. DOI: 10.3201/eid1805.111712.
[11]	KAMAR N, GARROUSTE C, HAAGSMA EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organtransplants[J]. Gastroenterology, 2011, 140(5): 1481-1489. DOI: 10.1053/j.gastro.2011.02.050.
[12]	KAMAR N, SELVES J, MANSUY JM, et al. Hepatitis E virus and chronic hepatitis inorgan-transplant recipients[J]. N Engl J Med, 2008, 358(8): 811-817. DOI: 10.1056/NEJMoa0706992.
[13]	AGGARWAL R. Hepatitis E: Does it cause chronic hepatitis E[J]. Hepatology, 2008, 48(4): 1328-1330. DOI: 10.1002 /hep.22548.
[14]	KAMAR N, WECLAWIAK H, GUILBEAU-FRUGIER C, et al. Hepatitis E virus and the kidney in solid-organ transplant patients[J]. Transplantation, 2012, 93(6): 617-23. DOI: 10.1097/TP.0b013e318245f14c.
[15]	DEL BELLO A, ARNE-BES MC, LAVAYSSIERE L, et al. Hepatitis E virus-induced severe myositis[J]. J Hepatol, 2012, 57(5): 1152-1153. DOI: 10.1016/j.jhep.2012.05.010.
[16]	TATON B, MOREAU K, LEPREUX S, et al. Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation[J]. Transpl Infect Dis, 2013, 15(6): e211-e215. DOI: 10.1111/tid.12143.
[17]	AGGARWAL A, PERUMPAIL RB, TUMMALA S, et al. Hepatitis E virus infection in the liver transplant recipients: Clinical presentation and management[J]. World J Hepatol, 2016, 8(2): 117-122. DOI: 10.4254/wjh.v8.i2.117.
[18]	ZHU FC, ZHANG J, ZHANG XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: A large-scale, randomised, double-blind placebo-controlled, phase 3 trial[J]. Lancet, 2010, 376(9744): 895-902. DOI: 10.1016/S0140-6736(10)61030-6.
[19]	ZHANG LX, WANG YY, CHEN YQ, et al. Review of infectious diseases in 2012[J]. Infect Dis Info, 2013, 26(1): 10-16. DOI: 10.3969/j.issn.1007-8134.2013.01.002. 张玲霞, 王永怡, 陈玉琪, 等. 2012年传染病热点回顾[J]. 传染病信息, 2013, 26(1): 10-16. DOI: 10.3969/j.issn.1007-8134.2013.01.002.